| Avril M Houston, MD | |
|
5600 Fishers Lane, Rockville, MD 20857 | |
| (301) 443-0842 | |
| Not Available |
| Full Name | Avril M Houston |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Adolescent Medicine |
| Location | 5600 Fishers Lane, Rockville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013951300 | NPI | - | NPPES |
| 434207101 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | D63288 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Avril M Houston, MD 5600 Fishers Lane, Rockville, MD 20857 Ph: (301) 443-0842 | Avril M Houston, MD 5600 Fishers Lane, Rockville, MD 20857 Ph: (301) 443-0842 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
A new report shows that while the overall rate of substance abuse treatment admissions among those aged 12 and older in the United States has remained nearly the same from 1999 to 2009, there has been a dramatic rise (430 percent) in the rate of treatment admissions for the abuse of prescription pain relievers during this period.
In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.
A new study published in the Journal for Healthcare Quality reveals that a multifaceted quality initiative can significantly reduce adverse obstetric outcomes, thereby improving patient safety and enhancing staff and patient experiences.
Mayo Clinic's Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Children's of Alabama announce their collaboration within a consortium to provide solutions for patients with hypoplastic left heart syndrome, a rare and complex form of congenital heart disease in which the left side of the heart is severely underdeveloped.
› Verified 2 days ago
Stacy B Stryer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Research Blvd, Suite 370, Rockville, MD 20850 Phone: 301-990-1664 Fax: 301-990-0471 | |
Dr. Faith E. Frankel, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1684 E Gude Dr, Rockville, MD 20850 Phone: 301-217-9222 | |
Mesfin Woldesenbet, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9901 Medical Center Dr, Rockville, MD 20850 Phone: 240-826-7392 Fax: 240-826-5388 | |
Dr. Aglae Economides, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 6000 Executive Blvd, Suite 625, Rockville, MD 20852 Phone: 240-314-7080 | |
Dr. Stanley J Kramer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2101 East Jefferson Street, Rockville, MD 20852 Phone: 301-816-6425 Fax: 301-816-7115 | |
Paul Sergio Porras, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2301 Research Blvd, Suite 115, Rockville, MD 20850 Phone: 301-990-1664 Fax: 301-990-0471 |